GL1X · GenesisL1 explorer

MolNFT v1 · #138090 · protein

Crystal structure of irak-4 with a 4,6-diaminonicotinamide inhibitor (compound number 9)

5W85 · Interleukin-1 receptor-associated kinase 4: “Crystal structure of irak-4 with a 4,6-diaminonicotinamide inhibitor (compound number 9)”. X-ray diffraction, 1 ligand (9YS), 4 pockets (best druggability 0.72). MolNFT v1 #138090 on…

PDB
5W85
Type
protein
Length
563 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Interleukin-1 receptor-associated kinase 4
EC
2.7.11.1
UniProt
Q9NWZ3
Ligands
9YS
Pockets
4 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInterleukin-1 receptor-associated kinase 4 (EC 2.7.11.1)protein28142% helix, 17% strandQ9NWZ3
BInterleukin-1 receptor-associated kinase 4 (EC 2.7.11.1)protein28241% helix, 17% strandQ9NWZ3

Ligands and binding sites

  • 9YS · 6-[(1,3-benzothiazol-6-yl)amino]-4-{[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino}-N-methylpyridine-3-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17550.720.7851empty
24320.700.81439YS
33470.660.80409YS
4680.300.7420empty

Interfaces

1 interface between chains.

  • A–B · 666 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 modified (phosphorylation).

Compared structures

  • 5W85 · Crystal structure of irak-4 with a 4,6-diaminonicotinamide inhibitor (compound number 9) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.